Clinical Trial Update: Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study of Alvespimycin hydrochloride in patients with metastatic or unresectable solid tumors has been completed, evaluating safety and preliminary activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Gastric Cancer
• Head and Neck Cancer
• Melanoma
• Ovarian Epithelial Cancer
• Prostate Cancer
• Renal Cell Carcinoma

Drugs mentioned

• Alvespimycin hydrochloride (alvespimycin hydrochloride)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Male Breast Cancer, Recurrent Adenoid Cystic Carcinoma of the Oral Cavity | Phase 1 | Status: COMPLETED